Services
Online Inquiry

For research use only. Not intended for any clinical use.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Non-Human Primate (NHP) PBMC & Immune Cell Biobanking Service

Are you currently facing challenges with inconsistent quality or limited supply of primary immune cells for your immunological studies? Our NHP PBMC & Immune Cell Biobanking service helps you accelerate your research and obtain high-quality, functional cells by leveraging our expertise in meticulous sample collection, advanced isolation techniques, and expert cryopreservation protocols. We ensure a reliable source of translational material for your projects through our stringent quality control and standardized processes.

Introduction of NHP PBMCs & Immune Cell Biobanking Service

For over two decades, NHPs have served as the most predictive animal models for human immune responses, making them indispensable in pre-clinical research. Their high genetic and physiological similarity to humans provides a reliable bridge between in vitro studies and human clinical trials, particularly in immunology, virology, and vaccine development. Our service is designed to harness this advantage, providing you with a consistent supply of premium NHP immune cells.

What Is Our Service?

This specialized service provides the full scope of obtaining, processing, and cryopreserving NHP peripheral blood mononuclear cells (PBMCs) and their specific immune cell subsets for future use. It offers a comprehensive solution for researchers who require a steady source of well-characterized immune cells without the logistical complexities of in-house collection and processing.

Our services are essential for a wide range of applications, including:

  • Vaccine and Immunotherapy Efficacy Testing: Evaluating the immune response to novel therapeutics by analyzing cell proliferation, cytokine release, and antibody-dependent cellular cytotoxicity (ADCC) experiments.
  • Infectious Disease Research: Studying host-pathogen interactions and understanding the cellular mechanisms of diseases that closely mimic human conditions.
  • Toxicology and Drug Safety Studies: Assessing the potential immunotoxicity of new drug candidates on key immune cell populations before they enter human trials.

Why Choose Us?

Partnering with Creative Biolabs addresses the key pain points often encountered in sourcing NHP biologicals:

  • To overcome Inconsistent Cell Viability: We deliver high-viability, functional cells through optimized cryopreservation protocols and stringent quality assurance, minimizing experimental variability and saving you valuable time and resources.
  • To overcome Difficulties in Sourcing and Logistics: We manage the entire process, from ethical NHP sourcing to secure distribution, providing you with a reliable and seamless supply chain.
  • To overcome Unreliable Data and Documentation: Every sample is accompanied by comprehensive metadata and a detailed Certificate of Analysis, giving you the transparency and confidence needed for regulatory submissions.

Generation of non-human primate CAR Tregs. (OA Literature)Fig.1 Procedure for the Generation of CAR T Regulatory Cells in NHPs.1

Key Benefits of Our Service

Our NHP PBMC & Immune Cell Biobanking service offers distinct advantages that set your research on a path to success. We prioritize speed, customization, and quality to meet the precise needs of your projects.

  • Accelerated Response Speed: Our established relationships and optimized protocols enable rapid response and processing. We can typically provide initial project quotes and turnaround estimates within 24 hours of your inquiry, ensuring your research timeline is not delayed.
  • Extensive NHP Resources: We maintain access to a diverse and ethically-sourced population of non-human primates, including cynomolgus and rhesus macaques, allowing for a consistent supply of materials for your long-term studies.
  • Customization to Your Project Needs: Whether you require specific volumes, particular cell subsets (CD3+, CD4+, CD8+, CD14+, B cells, etc.), or specific processing conditions, we offer fully customizable services. This flexibility ensures the final product is perfectly tailored to your experimental design.
  • Reporting Depth & Transparency: Our detailed reports go beyond basic viability counts. We provide comprehensive data on cell purity, cell counts, and post-thaw functional assessments, all documented in a clear, easy-to-understand format. Published data and our internal quality control metrics support the reliability of our methods.

How Creative Biolabs' Services Can Assist Your Project?

Our service provides a clear, reliable, and transparent pathway from project conception to final data. We deliver high-quality, pre-screened, and biobanked NHP immune cells that are ready for your downstream assays, eliminating the need for you to manage complex and time-consuming cell processing.

01

Initial Consultation & Protocol Design

02

Ethical Sourcing & Sample Collection

03

Advanced Isolation & Quality Control

04

Cryopreservation & Biobanking

05

Data Reporting & Secure Distribution

Key Deliverables

Upon completion of your project, you will receive a comprehensive package of materials and data to support your research:

  • Cryopreserved vials of NHP PBMCs or specific immune cell subsets.
  • A detailed Lab Report outlining the entire processing workflow.
  • A Certificate of Analysis confirming cell viability, count, and purity.
  • Raw Data from flow cytometry analysis and other quality control checks.
  • Associated metadata about the donor animals (species, age, sex, health status).

Capabilities & Partnerships

Service-Specific Data

  • Annual Sample Size: 5,000 NHP samples processed
  • Turnaround Time (TAT): 2-4 weeks for most projects
  • Post-Thaw Viability Pass Rate: > 80%

Partner Institutions

Frequently Asked Questions

Q: Why should I use cryopreserved NHP PBMCs instead of fresh samples?
A: Cryopreserved cells offer unparalleled consistency and convenience. They eliminate the variability associated with fresh samples, which can degrade rapidly, and allow you to schedule your experiments without being constrained by collection timelines. This ensures your data is more reproducible and your research can proceed more efficiently.
Q: How do you ensure the quality and viability of the cells after cryopreservation?
A: We follow a rigorous quality control protocol. After cryopreservation, we thaw a small test sample to verify post-thaw viability (typically >80%) and purity using methods like flow cytometry. Our controlled-rate freezing process and validated cryoprotective media are designed specifically to maximize cell recovery and function.
Q: Can Creative Biolabs provide specific immune cell subsets beyond just PBMCs?
A: Absolutely. Our service is fully customizable. We can isolate a wide range of purified immune cell subsets, such as CD3+, CD4+, CD8+, CD14+, and B cells, using advanced immunomagnetic selection technologies. Simply let us know your specific needs during the initial consultation.
Q: What information about the donor animals is provided with the samples?
A: We provide comprehensive metadata for each sample, including the species, age, sex, and health status of the donor animal. This detailed documentation is crucial for selecting the most appropriate samples for your study and for regulatory compliance.
Q: Are your NHP samples ethically sourced and handled?
A: Yes, ethical sourcing is a core principle of our operations. We work exclusively with certified facilities that adhere to the highest standards of animal welfare and regulatory compliance. Our protocols are designed to minimize stress on the animals, ensuring the well-being of the NHPs while providing you with high-quality samples.

Contact Us

At Creative Biolabs, we are committed to being your trusted partner in immunological research. Our NHP PBMCs & Immune Cell Biobanking service provides a high-quality, reliable, and consistent source of translational materials, empowering you to accelerate your discoveries. Ready to advance your research with our premium NHP immune cell services? Contact our team today for detailed information and to discuss your project requirements.

Reference

  1. Ellis, Gavin I et al. "Generation of non-human primate CAR Tregs using artificial antigen-presenting cells, simian tropic lentiviral vectors, and antigen-specific restimulation." STAR protocols vol. 3,4 101784. 5 Nov. 2022. Distributed under Open Access license CC BY 4.0, without modification. DOI: https://doi.org/10.1016/j.xpro.2022.101784
Cart
Cart